Clinical and Histopathological Findings of Multiple Sparganosis in a Patient with Primary Myelofibrosis

Q4 Medicine

Journal of Mycology and Infection Pub Date : 2022-09-30 DOI:10.17966/jmi.2022.27.3.55

H. Oh, S. Yoo, Marianne Isabel A. Sayo, J. H. Lee

引用次数: 0

Abstract

Previous reports of sparganosis have verified the effects of immunosuppressive therapy to the onset of sparganosis 2 . Other reports have also found the absence of eosinophilia, presumably related to the immunosuppressive state of the patient. This indicates that the normal predictive value of eosinophilia on blood tests is unlikely to be present in patients with immunosuppression cases of multiple sparganosis which has been most frequently reported in immunocompromised patients. This underscores the importance of not only sus-pecting a parasitic infection in immunocompromised patients with a movable mass, but also taking all necessary steps to avoid the parasite from disseminating throughout the body including close observation.

查看原文本刊更多论文

原发性骨髓纤维化患者多发性稀疏瘤的临床和组织病理学表现

先前关于裂头蚴病的报道已经证实了免疫抑制治疗对裂头线虫病2的发病的影响。其他报告也发现没有嗜酸性粒细胞增多，可能与患者的免疫抑制状态有关。这表明血液测试中嗜酸性粒细胞增多症的正常预测值不太可能出现在免疫抑制的多发性裂头蚴病患者中，而免疫功能低下的患者最常报告这种情况。这强调了不仅要发现具有可移动肿块的免疫功能受损患者的寄生虫感染，而且要采取一切必要措施避免寄生虫在全身传播，包括密切观察。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Journal of Mycology and Infection Medicine-Infectious Diseases

CiteScore

0.20

自引率

0.00%

发文量

期刊介绍： The Journal of mycology and infection (Acronym: JMI, Abbreviation: J Mycol Infect) aims to publish articles of exceptional interests in the field of medical mycology. The journal originally was launched in 1996 as the Korean Journal of Medical Mycology and has reformed into the current state beginning on March of 2018. The contents of the journal should elucidate important microbiological fundamentals and provide qualitative insights to respective clinical aspects. JMI underlines the submission of novel findings and studies in clinical mycology that are enriched by analyses achieved through investigative methods. The journal should be of general interests to the scientific communities at large and should provide medical societies with advanced breadth and depth of mycological expertise. In addition, the journal supplements infectious diseases in adjunct to the field of mycology to address a well-rounded understanding of infectious disorders. The Journal of mycology and infection, which is issued quarterly, in March, June, September and December each year, published in English. The scope of the Journal of mycology and infection includes invited reviews, original articles, case reports, letter to the editor, and images in mycology. The journal is compliant to peer-review/open access and all articles undergo rigorous reviewing processes by our internationally acknowledged team of editorial boards. The articles directed to publication should encompass in-depth materials that employ scholastic values of mycology and various infectious diseases. Articles responding to critical methodology and outcomes which have potential to enhance better understanding of mycology and infectious diseases are also suitable for publication.